造影剤の世界市場予測(~2022年):ヨード造影剤、ガドリニウム、バリウム、マイクロバブル

◆英語タイトル:Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022
◆商品コード:MD-3577
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2017年11月23日
◆ページ数:178
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
MarketsandMarketsが発行した当調査レポートでは、造影剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、用途別分析、地域別分析、造影剤の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global contrast media/contrast agents market is projected to reach USD 5.53 Billion by 2022 from an estimated USD 4.57 Billion in 2017, growing at a CAGR of 3.9% during the forecast period. This growth can be attributed to factors such as increasing approvals for contrast agents and growing number of public and private diagnostic centers.
On the basis of type, the market is categorized into barium-based, iodinated contrast media, gadolinium-based, and microbubble-based contrast media. The iodinated contrast media segment is expected to command the largest share of the contrast media market in 2017. The high share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.

On the basis of modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2017, X-ray/CT procedures are expected to command the largest share of the global contrast media market. However, the ultrasound segment is expected to grow at the highest CAGR from 2017 to 2022. Growth in the ultrasound segment can largely be attributed to several advantages offered by ultrasound contrast agents over other contrast agents and the rising number of approvals for ultrasound contrast agents in the US, Europe, and Japan.

On the basis of indication, the market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to command the largest share and highest growth rate during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in developed countries are some of the factors driving this segment.

On the basis of route of administration, the market is categorized into oral, intravascular, rectal, and other routes. The intravascular route segment is expected to command the largest share of the contrast media market in 2017. This segment is also expected to grow at the highest CAGR from 2017 to 2022. Growth in this segment can largely be attributed to advancements in CT and MRI imaging technologies that majorly use the intravascular route to inject contrast media.

On the basis application, the market is segmented into radiology, interventional radiology, and interventional cardiology. In 2017, the radiology segment is expected to command the largest share of the global contrast media market. However, the interventional cardiology segment is expected to grow at the highest CAGR from 2017 to 2022. Growth in the interventional cardiology segment can largely be attributed to factors such increasing demand for minimally invasive surgical procedures across the globe and rising burden of cardiovascular diseases.

Geographically, the North American market is expected to account for the largest share of the global contrast media market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period. This growth can be attributed to the increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries.

Various side effects and allergic reactions associated with the use of contrast media limit the usage of these agents in the medical imaging, thereby restricting the market to some extent.

GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the contrast media market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.1.2.1 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Executive Summary (Page No. – 30)
3.1 Introduction

4 Premium Insights (Page No. – 35)
4.1 Contrast Media/Contrast Agents: Market Overview
4.2 Asia Pacific Contrast Media/Contrast Agents Market, By Type
4.3 Geographic Snapshot: Contrast Media/Contrast Agents Market
4.4 Global Contrast Media/Contrast Agents, By Indication
4.5 Global Contrast Media/Contrast Agents Market, By Modality

5 Market Overview (Page No. – 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Public & Private Diagnostic Centers
5.2.1.2 Large Number of Approvals for Contrast Agents
5.2.2 Restraints
5.2.2.1 Side Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunities
5.2.3.1 Entry of Generic Contrast Media Products
5.2.3.2 Increasing Research Activities for Contrast Agents
5.2.4 Challenges
5.2.4.1 Technological Advancements in Imaging Solutions
5.2.4.2 Restriction and Withdrawal of Linear Gadolinium-Based Contrast Agents

6 Pipeline Assessment (Page No. – 45)
6.1 Introduction
6.2 Clinical Trails Using Contrast Media
6.3 Product Pipeline

7 Global Contrast Media/Contrast Agents Market, By Type (Page No. – 52)
7.1 Introduction
7.2 Iodinated Contrast Media
7.3 Gadolinium-Based Contrast Media
7.4 Microbubble Contrast Media
7.5 Barium-Based Contrast Media

8 Global Contrast Media/Contrast Agents Market, By Modality (Page No. – 59)
8.1 Introduction
8.2 X-Ray/CT
8.3 Magnetic Resonance Imaging
8.4 Ultrasound

9 Global Contrast Media/Contrast Agents Market, By Indication (Page No. – 65)
9.1 Introduction
9.2 Cardiovascular Disorders
9.3 Cancer
9.4 Gastrointestinal Disorders
9.5 Musculoskeletal Disorders
9.6 Neurological Disorders
9.7 Nephrological Disorders

10 Global Contrast Media/Contrast Agents Market, By Route of Administration (Page No. – 74)
10.1 Introduction
10.2 Intravascular
10.3 Oral
10.4 Rectal
10.5 Other Routes

11 Global Contrast Media/Contrast Agents Market, By Application (Page No. – 80)
11.1 Introduction
11.2 Radiology
11.3 Interventional Radiology
11.4 Interventional Cardiology

12 Global Contrast Media/Contrast Agents Market, By Region (Page No. – 85)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 RoE
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 RoAPAC
12.5 Rest of the World

13 Competitive Landscape (Page No. – 136)
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Scenario
13.3.1 Market Developments (Regulatory and Product Approvals)
13.3.2 Agreements, Collaborations, Contracts, and Partnerships
13.3.3 Expansions
13.3.4 Mergers and Acquisitions
13.3.5 Other Strategies

14 Company Profiles (Page No. – 143)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
14.1 GE Healthcare
14.2 Bayer
14.3 Bracco Imaging
14.4 Guerbet
14.5 Lantheus
14.6 Daiichi Sankyo
14.7 Unijules Life Sciences
14.8 Spago Nanomedical
14.9 J.B. Chemicals and Pharmaceuticals
14.10 Magnus Health
14.11 Taejoon Pharm
14.12 Jodas

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. – 168)
15.1 Insights of Industry Experts
15.2 Discussion Guide
15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
15.4 Introducing RT: Real-Time Market Intelligence
15.5 Available Customizations
15.6 Related Reports
15.7 Author Details

List of Tables (107 Tables)

Table 1 Indicative List of Research Studies Undertaken By Research Institutes and Universities
Table 2 Indicative List of Clinical Trials Conducted for Contrast Media/ Contrast Agents
Table 3 Indicative List of the Product Pipeline for Contrast Media/Contrast Agents
Table 4 Contrast Media/Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 5 Iodinated Contrast Media/Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 6 Gadolinium-Based Contrast Media/Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 7 Microbubble Contrast Media/Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 8 Barium-Based Contrast Media/Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 9 Contrast Media/Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 10 X-Ray/CT Contrast Media/Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 11 Mri Contrast Media/Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 12 Ultrasound Contrast Media/Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 13 Contrast Media/Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 14 Contrast Media /Contrast Agents Market for Cardiovascular Disorders, By Region, 2015–2022 (USD Million)
Table 15 Contrast Media /Contrast Agents Market for Cancer, By Region, 2015–2022 (USD Million)
Table 16 Contrast Media /Contrast Agents Market for Gastrointestinal Disorders, By Region, 2015–2022 (USD Million)
Table 17 Contrast Media /Contrast Agents Market for Musculoskeletal Disorders, By Region, 2015–2022 (USD Million)
Table 18 Contrast Media /Contrast Agents Market for Neurological Disorders, By Region, 2015–2022 (USD Million)
Table 19 Contrast Media /Contrast Agents Market for Nephrological Disorders, By Region, 2015–2022 (USD Million)
Table 20 Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 21 Intravascular Contrast Media /Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 22 Oral Contrast Media /Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 23 Rectal Contrast Media /Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 24 Other Contrast Media /Contrast Agents Market, By Region, 2015–2022 (USD Million)
Table 25 Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 26 Contrast Media /Contrast Agents Market for Radiology, By Region, 2015–2022 (USD Million)
Table 27 Contrast Media /Contrast Agents Market for Interventional Radiology, By Region, 2015–2022 (USD Million)
Table 28 Contrast Media /Contrast Agents Market for Interventional Cardiology, By Region, 2015–2022 (USD Million)
Table 29 North America: Contrast Media /Contrast Agents Market, By Country, 2015–2022 (USD Million)
Table 30 North America: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 31 North America: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 32 North America: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 33 North America: Contrast Media /Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 34 North America: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 35 US: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 36 US: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 37 US: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 38 US: Contrast Media /Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 39 US: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 40 Indicative List of Research Projects in Canada, 2014–2017
Table 41 Canada: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 42 Canada: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 43 Canada: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 44 Canada: Contrast Media /Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 45 Canada: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 46 Europe: Contrast Media /Contrast Agents Market, By Country, 2015–2022 (USD Million)
Table 47 Europe: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 48 Europe: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 49 Europe: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 50 Europe: Contrast Media /Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 51 Europe: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 52 Germany: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 53 Germany: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 54 Germany: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 55 Germany: Contrast Media /Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 56 Germany: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 57 UK: Contrast Media /Contrast Agents Market, By Modality , 2015–2022 (USD Million)
Table 58 UK: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 59 UK: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 60 UK: Contrast Media /Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 61 UK: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 62 France: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 63 France: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 64 France: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 65 France: Contrast Media /Contrast Agents Market, By Indication, 2015–2022 (USD Million)
Table 66 France: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 67 RoE: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 68 RoE: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 69 RoE: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 70 RoE: Contrast Media /Contrast Agents Market, By Indication 2015–2022 (USD Million)
Table 71 RoE: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 72 Asia Pacific: Contrast Media /Contrast Agents Market, By Country, 2015–2022 (USD Million)
Table 73 APAC: Contrast Media /Contrast Agents Market, By Modality , 2015–2022 (USD Million)
Table 74 APAC: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 75 APAC: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 76 APAC: Contrast Media /Contrast Agents Market, By Indication 2015–2022 (USD Million)
Table 77 APAC: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 78 China: Contrast Media /Contrast Agents Market, By Modality , 2015–2022 (USD Million)
Table 79 China: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 80 China: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 81 China: Contrast Media /Contrast Agents Market, By Indication 2015–2022 (USD Million)
Table 82 China: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 83 Japan: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 84 Japan: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 85 Japan: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 86 Japan: Contrast Media /Contrast Agents Market, By Indication 2015–2022 (USD Million)
Table 87 Japan: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 88 India: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 89 India: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 90 India: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 91 India: Contrast Media /Contrast Agents Market, By Indication 2015–2022 (USD Million)
Table 92 APAC: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 93 RoAPAC: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 94 RoAPAC: Contrast Media /Contrast Agents Market, By Type, 2015–2022 (USD Million)
Table 95 RoAPAC: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 96 RoAPAC: Contrast Media /Contrast Agents Market, By Indication 2015–2022 (USD Million)
Table 97 RoAPAC: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 98 RoW: Contrast Media /Contrast Agents Market, By Modality, 2015–2022 (USD Million)
Table 99 RoW: Contrast Media /Contrast Agents Market, By Type, 2015-2022 (USD Million)
Table 100 RoW: Contrast Media /Contrast Agents Market, By Route of Administration, 2015–2022 (USD Million)
Table 101 RoW: Contrast Media /Contrast Agents Market, By Indication 2015–2022 (USD Million)
Table 102 RoW: Contrast Media /Contrast Agents Market, By Application, 2015–2022 (USD Million)
Table 103 Market Developments (Regulatory and Product Approvals)
Table 104 Agreements, Collaborations, Contracts, and Partnerships
Table 105 Expansions
Table 106 Mergers and Acquisitions
Table 107 Other Strategies

List of Figures (42 Figures)

Figure 1 Research Methodology: Global Contrast Media/Contrast Agents Market
Figure 2 Research Design
Figure 3 Key Data From Primary Sources
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Sampling Frame: Primary Research
Figure 6 Market Size Estimation Methodology: Bottom-Up Approach
Figure 7 Market Size Estimation Methodology: Top-Down Approach
Figure 8 Data Triangulation Methodology
Figure 9 Contrast Media/Contrast Agents Market, By Modality (2017)
Figure 10 Contrast Media/Contrast Agents Market, By Route of Administration, 2017 vs 2022
Figure 11 Contrast Media/Contrast Agents Market, By Indication, 2017 vs 2022
Figure 12 Contrast Media/Contrast Agents Market Analysis, By Application, 2017 vs 2022
Figure 13 Contrast Media/Contrast Agents Market, By Type, 2017 vs 2022
Figure 14 Asia Pacific is Slated to Witness the Highest Growth in the Contrast Media/Contrast Agents Market During the Forecast Period
Figure 15 North America to Account for the Largest Market Share in 2017
Figure 16 Japan to Account for the Largest Share of the Asia Pacific Contrast Media/Contrast Agents Market (2017)
Figure 17 China to Witness Highest Growth During the Forecast Period
Figure 18 Cardiovascular Disorders to Command the Largest Market Share in 2017 and 2022
Figure 19 X-Ray/CT to Command the Largest Market Share in 2017
Figure 20 Contrast Media/Contrast Agents: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Clinical Trials for Contrast Media/Contrast Agents, By Phase (2014 Onwards)
Figure 22 Clinical Trials for Contrast Media/Contrast Agents, By Indication (2014 Onwards)
Figure 23 Microbubble Contrast Media/Contrast Agents Segment to Register the Highest Growth During the Forecast Period
Figure 24 Ultrasound to Register Highest CAGR During the Forecast Period
Figure 25 Cardiovascular Disorders to Dominate the Contrast Media/Contrast Agents Market in 2017
Figure 26 Intravascular Route of Administration, the Fastest-Growing Segment in the Contrast Media /Contrast Agents Market
Figure 27 Radiology is Expected to Be the Largest Application Segment in the Contrast Media /Contrast Agents Market in 2017
Figure 28 North America to Account for the Largest Share of the Contrast Media /Contrast Agents Market in 2017
Figure 29 North America: Contrast Media /Contrast Agents Market Snapshot
Figure 30 Prevalence of Alzheimer’s in the Us, By Age Group, 2015
Figure 31 Europe: Contrast Media /Contrast Agents Market Snapshot
Figure 32 Asia Pacific: Contrast Media /Contrast Agents Market Snapshot
Figure 33 RoW: Contrast Media /Contrast Agents Market Snapshot
Figure 34 Global Contrast Media Market Share, By Key Player, 2016
Figure 35 Key Developments of the Prominent Players in the Contrast Media /Contrast Agents Market (2014-2017)
Figure 36 GE Healthcare: Company Snapshot
Figure 37 Bayer: Company Snapshot
Figure 38 Guerbet Group: Company Snapshot
Figure 39 LantheUS: Company Snapshot
Figure 40 Daiichi Sankyo: Company Snapshot
Figure 41 Spago Nanomedical: Company Snapshot
Figure 42 J.B. Chemicals and Pharmaceuticals: Company Snapshot



【レポートのキーワード】

造影剤、ヨード造影剤、ガドリニウム、バリウム、マイクロバブル、X線検査、CT、MRI、超音波、医療

★調査レポート[造影剤の世界市場予測(~2022年):ヨード造影剤、ガドリニウム、バリウム、マイクロバブル] (コード:MD-3577)販売に関する免責事項を必ずご確認ください。
★調査レポート[造影剤の世界市場予測(~2022年):ヨード造影剤、ガドリニウム、バリウム、マイクロバブル]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆